References
Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009;44(7):793–8.
Weinmann H-J, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med. 1991;22:233–7.
Ni Y, Marchal G, Yu J, Mühler A, Lukito G, Baert AL. Prolonged positive enhancement by Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J Magn Reson Imaging. 1994;4:355–63.
Ni Y, Marchal G. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging. 1998;9(3):183–95.
Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology. 1996;200:59–67.
Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol. 1997;7:275–80.
Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT––initial observations. Radiology. 2005;234:468–78.
Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. 2008;43:504–11.
Ni Y, Wang H, Chen F, Li J, Feng Y, DeKeyzer F, et al. Tumor models and specific contrast agents for small animal imaging in oncology. Methods. 2009;48:125–38.
Fujita M, Yamamoto R, Takahashi M, Tsuji T, Yamanaka T, Miyazawa T, et al. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis. J Magn Reson Imaging. 1997;7:768–70.
Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium–ethoxybenzyl–diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol. 2004;39:80–8.
Fujita M, Yamamoto R, Fritz-Zieroth B, Yamanaka T, Takahashi M, Miyazawa T, et al. Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide. J Magn Reson Imaging. 1996;6(3):472–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s00535-009-0176-x.
Rights and permissions
About this article
Cite this article
Ni, Y., Chen, F., Wang, H. et al. Proper definitions of MRI contrast enhancement in liver tumors. J Gastroenterol 45, 349–350 (2010). https://doi.org/10.1007/s00535-009-0174-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-009-0174-z